Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Conditions:   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1 Interventions:   Drug: 3 hours humulin R 100 IU/mL PIT;   Drug: 2 hours humulin R 100 IU/mL PIT Sponsors:   Sciema UG;   Innovative Diabetes Treatment Studies LLC. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials